5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamide

has antineoplastic activity; structure in first source

Also Known As:

5- (2,4- dihydroxy- 5- isopropylphenyl)- N- ethyl- 4- (4- (morpholinomethyl)phenyl)isoxazole- 3- carboxamide; AUY922; NVP-AUY922; VER 52296; VER-52296; VER52296; luminespib

Heterocyclic Compounds: 207
- 1-Ring Heterocyclic Compounds
  - Azoles: 2199
    - Isoxazoles: 162
      - 5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide: 133
Organic Chemicals: 140
- Hydrocarbons: 1726
  - Cyclic Hydrocarbons: 96
    - Aromatic Hydrocarbons: 295
      - Benzene Derivatives: 17
        Phenols: 702
        Resorcinols: 4
        5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide: 133

Sungwook Kwon Selected Research

Sungwook Kwon Research Topics

Disease

Drug/Important Bio-Agent (IBA)